Erudio Healtherudio.com
Clinical trial · no report yet · Phase not applicable
5STAR-PC
5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:
- NCT04245670 ↗
- Unknown
- Sunnybrook Health Sciences Centre
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- 5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:A Phase II Study (5STAR-PC)
- Phase
- Phase not applicable
- Status
- Unknown
- Conditions
- Prostate Cancer
- Interventions
- Stereotactic Ablative Body Radiotherapy (SABR) 35-50 Gy/5
- Arms
- Stereotactic Ablative Body Radiotherapy (SABR) 35-50 Gy/5 · Experimental
- Enrollment
- 75 (estimated)
- Primary outcomes
- Acute Toxicity
- Acute Toxicity
- Sponsor
- Sunnybrook Health Sciences Centre with Prostate Cure Foundation
- Start
- May 31, 2018
- Primary completion
- Aug 30, 2021
- Results posted
- No
- Registry record
- NCT04245670 · updated Sep 28, 2022